Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5835900 | 0.92 | MAPT (0.38) | MAPTUSP2ALDH1A1ALOX15TDP1 | |
| SCHEMBL30557998 | 0.89 | MAPT (0.36) | MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1149970 | 0.89 | MAPT (0.36) | MAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15748587 | 0.88 | MAPT (0.36) | MAPT | |
| SCHEMBL17192518 | 0.88 | MAPT (0.36) | MAPT | |
| SCHEMBL3677465 | 0.87 | MAPT (0.35) | MAPTNPC1RAB9ATSHRSMN1; SMN2 | |
| SCHEMBL15748039 | 0.86 | MAPT (0.36) | MAPT | |
| SCHEMBL3677421 | 0.85 | EPHX1 (0.35) | MAPTNPC1RAB9ATSHRSMN1; SMN2 | |
| SCHEMBL15748145 | 0.85 | EPHX1 (0.35) | MAPTNPC1RAB9ATSHRSMN1; SMN2 | |
| SCHEMBL3677424 | 0.85 | EPHX1 (0.35) | MAPTNPC1RAB9ATSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730298-B1 | SPECIFIC SUBSTRATES FOR O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (CH) | 2015-11-11 | — | — | EP | disclosed |
| US-8163479-B2 | Specific substrates for O6-alkylguanine-DNA alkyltransferase | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2012-04-24 | — | — | US | disclosed |
| US-7723423-B2 | Gas-barrier resin composition | CRYOVAC, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| EP-1746131-B1 | Gas-barrier resin composition | CRYOVAC INC (US) | 2009-01-21 | — | — | EP | disclosed |
| US-7285598-B2 | Polymer and process for producing the same | KURARAY CO., LTD. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2007-10-18 | — | — | US | disclosed |
| US-20070093599-A1 | Gas-barrier resin composition | CRYOVAC, INC. (US) | 2007-04-26 | — | — | US | disclosed |
| US-20070021556-A1 | Gas-barrier resin composition | KURARAY CO. LTD. (JP) | 2007-01-25 | — | — | US | disclosed |
| EP-1746131-A2 | Gas-barrier resin composition | Cryovac, Inc. (US) | 2007-01-24 | — | — | EP | disclosed |
| EP-1730298-A1 | SPECIFIC SUBSTRATES FOR O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL Ecole Polytechnique Fédérale de Lausanne (CH) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005085470-A9 | SPECIFIC SUBSTRATES FOR O6- ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FEDERALE LAUSANNE (CH) | 2006-10-05 | — | — | WO | disclosed |
| US-20060149009-A1 | Produced by ring-opening, in the presence of a metal alkylidene complex comprising a ligand with an imidazolidine structure, a cyclic olefin comprising at least one cyclic olefin further comprising a hydroxy group or a functional group that can be converted into a hydroxy group, and hydrogenating | KURARAY CO., LTD. (JP) | 2006-07-06 | — | — | US | disclosed |
| EP-1598384-A1 | NOVEL POLYMER AND PROCESS FOR PRODUCING THE SAME | KURARAY CO., LTD. (JP) | 2005-11-23 | — | — | EP | disclosed |
| WO-2005085470-A1 | SPECIFIC SUBSTRATES FOR O6- ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2005-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | AGT, AGXT, AGTR1 | MAPT 3930/4885NPC1 3880/4885RAB9A 4432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.